Search Results for: ANO6

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
Novel ALG10B ALG10 alpha-1,2-glucosyltransferase B
  • Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein
Novel ARID2 AT-rich interaction domain 2
  • RMTs methylate histone arginines
  • RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known
Novel C12orf40 chromosome 12 open reading frame 40
Novel CPNE8 copine 8
Novel GXYLT1 glucoside xylosyltransferase 1
Novel LRRK2 leucine rich repeat kinase 2
  • PTK6 promotes HIF1A stabilization
  • Fostamatinib
  • Lewy body dementia (LBD); Dementia with Lewy bodies (DLB)
  • Parkinson's disease (PD)
Novel MUC19 mucin 19, oligomeric
  • Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)
  • Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)
  • Defective GALNT12 causes colorectal cancer 1 (CRCS1)
  • Dectin-2 family
  • O-linked glycosylation of mucins
  • Termination of O-glycan biosynthesis
Novel PRICKLE1 prickle planar cell polarity protein 1
  • Asymmetric localization of PCP proteins
  • Progressive myoclonic epilepsy (PME), including: Lafora disease (LBD); Unverricht-Lundborg disease (ULD); Neuronal ceroid lipofuscinoses (NCL); Type I sialidosis; Action myoclonus-renal failure syndrome (AMRF); Type III Gaucher disease (GD)
Novel SLC2A13 solute carrier family 2 member 13
  • Inositol transporters

Page 1 out of 1 pages